Reducing recurrence of large colorectal polyps after removal
Official title: Reducing Neoplasia Recurrence After Endoscopic Resection of Large Colorectal Polyps
Run by Centre hospitalier de l'Université de Montréal (CHUM) · NCT06271941 · Data updated 2026-11-12
This study is testing if a new method called hybrid argon plasma coagulation can help prevent large colorectal polyps from coming back after they've been removed, compared to the usual treatment.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 892 (estimated) |
| Sponsor | Centre hospitalier de l'Université de Montréal (CHUM) Academic / other |
| Locations | 1 site (Montreal, Quebec) |
| Status | Recruiting |
| Started | July 19, 2024 |
| Main results expected | October 1, 2027 |
| Study ends | April 1, 2028 |
| Registry record updated | September 18, 2026 |
| Trial ID | NCT06271941 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older who are undergoing EMR for large colorectal laterally spreading lesions.
✕Probably not a fit
Patients with inflammatory bowel disease, poor general health, or those with invasive cancer in the polyp will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the effectiveness of hybrid argon plasma coagulation (h-APC) in reducing the recurrence of large colorectal polyps after endoscopic mucosal resection (EMR). Patients with large laterally spreading lesions (≥20mm) will be randomly assigned to receive either h-APC ablation or the standard snare tip soft coagulation (STSC) margin ablation. The trial aims to determine if the h-APC technique leads to lower rates of lesion recurrence compared to the current standard of care. Participants will undergo a standard colonoscopy preparation before the procedure, and the trial will be conducted at a single center in Montreal.
Why it matters
Potential benefit: If successful, this approach could significantly reduce the recurrence of colorectal polyps, thereby lowering the risk of colorectal cancer.
How similar studies have gone: While the specific approach of h-APC is novel, similar techniques have shown promise in reducing recurrence in other studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * adult ≥18 years old * patients undergoing EMR for a large (≥20mm) colorectal LSL * patients providing written and informed consent for study participation. Exclusion Criteria: * inflammatory bowel disease; * non-elective colonoscopy; * poor general health (American Society of Anesthesiologists classification \>III); * coagulopathy or thrombocytopenia (international normalized ratio ≥1.5 or platelets \<50 x 109/L); * pedunculated polyps (Paris class Ip, Isp); * overt signs of deep submucosal invasive cancer (JNET 3); * biopsy proven invasive carcinoma in a potential study polyp. * Pregnant women
Where it's running
-
Centre Hospitalier de l'Université de Montréal
Montreal, Quebec, Canada Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Comparing closure techniques after removing large colorectal polyps
This study tests if closing the site after removing large flat colorectal polyps can help prevent complications and reduce the chance of the polyps coming back.
-
Knife-assisted full-thickness resection for rectal lesions in a multicenter setting
A multicenter study tests knife-assisted full-thickness resection (kFTR) to remove rectal lesions in adults and see how well it works and how safe it is.
-
Personalized 3D Bioprinted Colorectal Cancer Microenvironment Model
This study tests patient-derived, 3D-bioprinted cancer models that include tumor, fibroblast, and immune cells to see if they can better predict how colorectal cancer will respond to treatment.
-
Integrated genomic and clinical database for cancer biomarker discovery
Researchers are building a combined genomic and clinical database at Samsung Medical Center to test biomarkers for cancer diagnosis, treatment choice, and predicting how well treatments work.
-
Prehabilitation with Resistance, Aerobic, or Both Before Colorectal Surgery
Four pre-surgery exercise options (resistance, aerobic, both, or none) will be tested to see which best reduces complications after colorectal cancer surgery.
-
Liver transplantation for colorectal cancer with liver metastases
This study follows adults with stage IV colorectal cancer whose disease is limited to the liver and who are getting a liver transplant as part of their cancer care to see how they fare over time.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.